enkephalin, methionine has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, K; Kuniyasu, H; Luo, Y; Moriwaka, Y; Ohmori, H; Sasahira, T; Sasaki, T; Tatsumoto, N; Yamashita, Y | 1 |
| McLaughlin, PJ; Rahn, KA; Zagon, IS | 1 |
2 other study(ies) available for enkephalin, methionine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Colorectal Neoplasms; Enkephalin, Methionine; ErbB Receptors; Humans; Liver Neoplasms; Lymphatic Metastasis; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; Neprilysin; Nitric Oxide; Receptors, Opioid, delta; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells.
Topics: Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Physiological Phenomena; Chemotaxis; Dose-Response Relationship, Drug; Enkephalin, Methionine; Humans; Membrane Glycoproteins; Naltrexone; Narcotic Antagonists; Neoplasm Invasiveness; Neoplasms; Opioid Peptides | 2007 |